Cartesian Therapeutics, Inc. (RNAC)

9.60 -3.71% (-0.37)

Over 6M: +26.3%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

6 8 10
Mar Apr May Jun Jul Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 24.4M Q3 '21 — Operating Cash Flow: -10.7M Q3 '21 — Free Cash Flow: -10.9M Q3 '21 — Net Income: -17.9M Q4 '21 — Revenue: 29.9M Q4 '21 — Operating Cash Flow: -31.5M Q4 '21 — Free Cash Flow: -31.7M Q4 '21 — Net Income: 12.2M Q1 '22 — Revenue: 34M Q1 '22 — Operating Cash Flow: -11.9M Q1 '22 — Free Cash Flow: -12.3M Q1 '22 — Net Income: 28.8M Q2 '22 — Revenue: 39.3M Q2 '22 — Operating Cash Flow: -12.3M Q2 '22 — Free Cash Flow: -12.4M Q2 '22 — Net Income: 8.6M Q3 '22 — Revenue: 20.7M Q3 '22 — Operating Cash Flow: 4.4M Q3 '22 — Free Cash Flow: 3.9M Q3 '22 — Net Income: -7.9M Q4 '22 — Revenue: 16.8M Q4 '22 — Operating Cash Flow: -11.8M Q4 '22 — Free Cash Flow: -12.1M Q4 '22 — Net Income: 13.2M Q1 '23 — Revenue: 5.9M Q1 '23 — Operating Cash Flow: -8.8M Q1 '23 — Free Cash Flow: -8.9M Q1 '23 — Net Income: -21.7M Q2 '23 — Revenue: 5.2M Q2 '23 — Operating Cash Flow: -9.9M Q2 '23 — Free Cash Flow: -9.9M Q2 '23 — Net Income: -11.4M Q3 '23 — Revenue: 6.6M Q3 '23 — Operating Cash Flow: -9.2M Q3 '23 — Free Cash Flow: -9.2M Q3 '23 — Net Income: -9M Q4 '23 — Revenue: 8.3M Q4 '23 — Operating Cash Flow: -23.3M Q4 '23 — Free Cash Flow: -23.4M Q4 '23 — Net Income: -177.7M Q1 '24 — Revenue: 5.8M Q1 '24 — Operating Cash Flow: -15.9M Q1 '24 — Free Cash Flow: -16.5M Q1 '24 — Net Income: -56.8M Q2 '24 — Revenue: 33.4M Q2 '24 — Operating Cash Flow: -14.4M Q2 '24 — Free Cash Flow: -16M Q2 '24 — Net Income: 13.8M Q3 '24 — Revenue: 387K Q3 '24 — Operating Cash Flow: 13.7M Q3 '24 — Free Cash Flow: 7.5M Q3 '24 — Net Income: -24.2M Q4 '24 — Revenue: -759K Q4 '24 — Operating Cash Flow: -7M Q4 '24 — Free Cash Flow: -7.7M Q4 '24 — Net Income: -10.3M Q1 '25 — Revenue: 1.1M Q1 '25 — Operating Cash Flow: -23.1M Q1 '25 — Free Cash Flow: -24.2M Q1 '25 — Net Income: -17.7M Q2 '25 — Revenue: 298K Q2 '25 — Operating Cash Flow: -17.5M Q2 '25 — Free Cash Flow: -20.1M Q2 '25 — Net Income: 15.9M Q3 '25 — Revenue: 452K Q3 '25 — Operating Cash Flow: -15.6M Q3 '25 — Free Cash Flow: -16.9M Q3 '25 — Net Income: -35.9M Q4 '25 — Revenue: 947K Q4 '25 — Operating Cash Flow: -17.7M Q4 '25 — Free Cash Flow: -18.2M Q4 '25 — Net Income: -92.6M Q1 '26 — Revenue: 78K Q1 '26 — Operating Cash Flow: -22.1M Q1 '26 — Free Cash Flow: -22.2M Q1 '26 — Net Income: -39.2M Q2 '26 — Revenue: 0 Q2 '26 — Operating Cash Flow: -21.1M Q2 '26 — Free Cash Flow: -21.4M Q2 '26 — Net Income: 15.8M -150M -100M -50M 0 50M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.0
SBC / sales 625.6%
Accruals -23.7%
Asset turnover 0.0046×
Capex / sales 141.0%
ROA -47.7%
ROCE -52.1%
EBITDA margin —
FCF margin —
Gross margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
ROE —
ROIC —

1 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.8
ND/EBITDA —
Cash runway 1.2 yr
Cash / Debt 2.8×
Debt payback 0.0 yr
Quick ratio 7.5×
F-score 1.3 pts
Debt / Eq —
Equity / Assets —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.6
Sales/sh Y/Y +44.0%
Sales CAGR 4Y -57.4%
Sales Q/Q -100.0%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Shares change —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.